NuVasive, Inc.
NUVA
NUVA was delisted on the 31st of August, 2023.
260 hedge funds and large institutions have $3.05B invested in NuVasive, Inc. in 2019 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 90 increasing their positions, 85 reducing their positions, and 30 closing their positions.
112% more call options, than puts
Call options by funds: $10.7M | Put options by funds: $5.06M
30% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 30
2% more funds holding
Funds holding: 255 → 260 (+5)
6% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 85
3% more capital invested
Capital invested by funds: $2.97B → $3.05B (+$78.6M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
Eminence Capital
New York
|
+$70.7M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$33.3M |
| 3 |
HM
HealthCor Management
New York
|
+$14.7M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$14.5M |
| 5 |
CC
Carlson Capital
Dallas,
Texas
|
+$9.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$44.6M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$42.6M |
| 3 |
YCMGA
York Capital Management Global Advisors
New York
|
-$36.3M |
| 4 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$22.2M |
| 5 |
Goldman Sachs
New York
|
-$21M |
NUVA Hedge Fund Activity: Q2 2019 in Review
260 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in NuVasive, Inc. (NUVA) for Q2 2019, worth a combined $3.05B — up 2.6% from $2.97B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new NUVA positions and 30 closed out — a net gain of 9 holders — while 90 added to existing stakes and 85 trimmed.
The largest buyer was Eminence Capital, opening a new position worth an estimated $70.7M. The largest seller was Champlain Investment Partners, cutting an estimated $44.6M.
- 260 institutional investors held NuVasive, Inc. (NUVA) as of Q2 2019, up from 255 in Q1 2019.
- Funds reported $3.05B of NuVasive, Inc. stock for Q2 2019, up 2.6% quarter-over-quarter.
- 39 funds opened new NuVasive, Inc. positions in Q2 2019 and 30 closed out, a net change of +9 holders.
- The largest NuVasive, Inc. buyer in Q2 2019 was Eminence Capital, an estimated $70.7M added.
- The largest NuVasive, Inc. seller in Q2 2019 was Champlain Investment Partners, an estimated $44.6M sold.
Based on aggregated 13F filings for Q2 2019.